T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Archrock
AROC
$6.01B
| $2.99M | ﹤0.01% |
119,951
+14,321
| +14% | +$332K |
|
1452
Barings BDC
BBDC
$977M
| $2.98M | ﹤0.01% |
311,542
| – | – |
|
|
ESGR
1453
DELISTED
Enstar Group
ESGR
| $2.97M | ﹤0.01% |
9,223
+894
| +11% | +$289K |
|
1454
Zentalis Pharmaceuticals
ZNTL
$252M
| $2.97M | ﹤0.01% |
979,855
-57,056
| -6% | -$187K |
|
1455
OceanFirst Financial
OCFC
$1.91B
| $2.97M | ﹤0.01% |
163,883
+53,532
| +49% | +$1.02M |
|
1456
CNO Financial Group
CNO
$5.11B
| $2.95M | ﹤0.01% |
79,364
-4,107
| -5% | -$153K |
|
1457
Cousins Properties
CUZ
$4.9B
| $2.95M | ﹤0.01% |
96,351
+10,376
| +12% | +$318K |
|
1458
Macy's
M
$6.2B
| $2.95M | ﹤0.01% |
174,158
+13,275
| +8% | +$212K |
|
1459
Guardant Health
GH
$21.2B
| $2.95M | ﹤0.01% |
96,404
-746,104
| -89% | -$21M |
|
1460
Sonoco
SON
$5.73B
| $2.94M | ﹤0.01% |
60,189
+4,978
| +9% | +$257K |
|
1461
Roivant Sciences
ROIV
$26.2B
| $2.94M | ﹤0.01% |
248,264
-25,367
| -9% | -$300K |
|
1462
Quaker Houghton
KWR
$2.94B
| $2.94M | ﹤0.01% |
20,850
-5,768
| -22% | -$910K |
|
1463
American States Water
AWR
$3.51B
| $2.93M | ﹤0.01% |
37,746
+2,689
| +8% | +$224K |
|
1464
Independence Realty Trust
IRT
$4.01B
| $2.9M | ﹤0.01% |
145,992
+14,854
| +11% | +$303K |
|
1465
American Healthcare REIT
AHR
$10.5B
| $2.89M | ﹤0.01% |
101,764
+55,651
| +121% | +$1.5M |
|
1466
Avnet
AVT
$7.82B
| $2.87M | ﹤0.01% |
54,925
-858
| -2% | -$46.5K |
|
1467
Preferred Bank
PFBC
$1.27B
| $2.87M | ﹤0.01% |
33,257
+3,852
| +13% | +$340K |
|
1468
Spire
SR
$4.9B
| $2.86M | ﹤0.01% |
42,195
+4,574
| +12% | +$306K |
|
1469
Exponent
EXPO
$3.19B
| $2.86M | ﹤0.01% |
32,053
+2,517
| +9% | +$254K |
|
1470
Monarch Casino & Resort
MCRI
$2.23B
| $2.85M | ﹤0.01% |
36,075
+7,933
| +28% | +$640K |
|
|
SWI
1471
DELISTED
SolarWinds Corporation Common Stock
SWI
| $2.85M | ﹤0.01% |
199,610
+20,094
| +11% | +$271K |
|
|
TGNA
1472
DELISTED
TEGNA Inc
TGNA
| $2.83M | ﹤0.01% |
154,792
+9,568
| +7% | +$167K |
|
1473
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.6B
| $2.83M | ﹤0.01% |
73,738
+125
| +0.2% | +$5.03K |
|
1474
Trinity Capital Inc.
TRIN
$1.72B
| $2.83M | ﹤0.01% |
195,524
| – | – |
|
1475
Neurogene
NGNE
$710M
| $2.82M | ﹤0.01% |
+123,291
| New | +$4.59M |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.